194 related articles for article (PubMed ID: 24660652)
1. Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational research.
Ma Y; Sun Z; de Matos R; Zhang J; Odunsi K; Lin B
OMICS; 2014 May; 18(5):280-97. PubMed ID: 24660652
[TBL] [Abstract][Full Text] [Related]
2. Uncovering molecular events associated with the chemosuppressive effects of flaxseed: a microarray analysis of the laying hen model of ovarian cancer.
Hales KH; Speckman SC; Kurrey NK; Hales DB
BMC Genomics; 2014 Aug; 15(1):709. PubMed ID: 25150550
[TBL] [Abstract][Full Text] [Related]
3. The hen as a model of ovarian cancer.
Johnson PA; Giles JR
Nat Rev Cancer; 2013 Jun; 13(6):432-6. PubMed ID: 23676850
[TBL] [Abstract][Full Text] [Related]
4. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
[TBL] [Abstract][Full Text] [Related]
5. Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics.
Lorkova L; Pospisilova J; Lacheta J; Leahomschi S; Zivny J; Cibula D; Zivny J; Petrak J
Oncol Rep; 2012 Feb; 27(2):318-24. PubMed ID: 22020625
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate biomarkers using the Experion™ automated electrophoresis system in serum samples from ovarian cancer patients.
Kim JH; Kim YW; Kim IW; Park DC; Kim YW; Lee KH; Jang CK; Ahn WS
Int J Oncol; 2013 Apr; 42(4):1257-62. PubMed ID: 23443953
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of combinatorial peptide ligand libraries for proteome capture evaluated by selected reaction monitoring.
Di Girolamo F; Righetti PG; Soste M; Feng Y; Picotti P
J Proteomics; 2013 Aug; 89():215-26. PubMed ID: 23747450
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer.
Han Y; Huang H; Xiao Z; Zhang W; Cao Y; Qu L; Shou C
PLoS One; 2012; 7(12):e52745. PubMed ID: 23300757
[TBL] [Abstract][Full Text] [Related]
9. Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Clarke CH; Yip C; Badgwell D; Fung ET; Coombes KR; Zhang Z; Lu KH; Bast RC
Gynecol Oncol; 2011 Sep; 122(3):548-53. PubMed ID: 21708402
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of alpha 2 macroglobulin in response to dietylstilbestrol and in ovarian carcinomas in chickens.
Lim W; Jeong W; Kim JH; Lee JY; Kim J; Bazer FW; Han JY; Song G
Reprod Biol Endocrinol; 2011 Oct; 9():137. PubMed ID: 21978460
[TBL] [Abstract][Full Text] [Related]
11. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
12. Protein biomarkers for early detection of diseases: The decisive contribution of combinatorial peptide ligand libraries.
Boschetti E; D'Amato A; Candiano G; Righetti PG
J Proteomics; 2018 Sep; 188():1-14. PubMed ID: 28882677
[TBL] [Abstract][Full Text] [Related]
13. The Unique Features of Proteins Depicting the Chicken Amniotic Fluid.
Da Silva M; Dombre C; Brionne A; Monget P; Chessé M; De Pauw M; Mills M; Combes-Soia L; Labas V; Guyot N; Nys Y; Réhault-Godbert S
Mol Cell Proteomics; 2019 Mar; 18(Suppl 1):S174-S190. PubMed ID: 29444982
[TBL] [Abstract][Full Text] [Related]
14. SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
Lim W; Kim HS; Jeong W; Ahn SE; Kim J; Kim YB; Kim MA; Kim MK; Chung HH; Song YS; Bazer FW; Han JY; Song G
PLoS One; 2012; 7(11):e49869. PubMed ID: 23185467
[TBL] [Abstract][Full Text] [Related]
15. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes.
Teng PN; Wang G; Hood BL; Conrads KA; Hamilton CA; Maxwell GL; Darcy KM; Conrads TP
Br J Cancer; 2014 Jan; 110(1):123-32. PubMed ID: 24178762
[TBL] [Abstract][Full Text] [Related]
17. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.
Tang HY; Beer LA; Chang-Wong T; Hammond R; Gimotty P; Coukos G; Speicher DW
J Proteome Res; 2012 Feb; 11(2):678-91. PubMed ID: 22032327
[TBL] [Abstract][Full Text] [Related]
18. Proteomics analysis for finding serum markers of ovarian cancer.
Cheng Y; Liu C; Zhang N; Wang S; Zhang Z
Biomed Res Int; 2014; 2014():179040. PubMed ID: 25250314
[TBL] [Abstract][Full Text] [Related]
19. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
[TBL] [Abstract][Full Text] [Related]
20. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
